- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/16 - Tryptamines
Patent holdings for IPC class C07D 209/16
Total number of patents in this class: 701
10-year publication summary
|
17
|
6
|
11
|
17
|
56
|
95
|
148
|
106
|
115
|
52
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Caamtech, Inc. | 155 |
83 |
| Compass Pathfinder Limited | 127 |
40 |
| Mindset Pharma Inc. | 68 |
36 |
| Enveric Biosciences Canada Inc. | 66 |
36 |
| Atai Therapeutics, Inc. | 95 |
21 |
| Cybin IRL Limited | 72 |
20 |
| Beckley Psytech Limited | 49 |
20 |
| Cybin UK Ltd | 44 |
19 |
| Terran Biosciences, Inc. | 109 |
17 |
| Gilgamesh Pharmaceuticals, Inc. | 63 |
15 |
| Psilo Scientific Ltd. | 54 |
14 |
| GH Research Ireland Limited | 91 |
9 |
| Psilera Inc. | 14 |
9 |
| Huxley Health Inc. | 21 |
9 |
| Zylorion Health Inc. | 14 |
9 |
| MagicMed Industries Inc. | 9 |
8 |
| Reunion Neuroscience Inc. | 20 |
8 |
| H. Lundbeck A/S | 1234 |
7 |
| Small Pharma Limited | 16 |
7 |
| Mydecine Innovations Group Inc. | 25 |
6 |
| Other owners | 308 |